Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162b2 vaccine
Athanasios Michos, Elizabeth‐Barbara Tatsi, Filippos Filippatos, Charilaos Dellis, Dimitra Koukou, Vasiliki Efthymiou, Evangelia Kastrinelli, Aimilia Mantzou, Vasiliki Syriopoulou
Topics & Concepts
MedicineAntibodyEpidemiologyImmunizationSpike ProteinCohortCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Neutralizing antibodyInternal medicineImmunologyDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies